Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1561929
Reference Type
Journal Article
Title
Ginkgo biloba Extract Attenuates Hyperalgesia in a Rat Model of Vincristine-Induced Peripheral Neuropathy
Author(s)
Park, H; Lee, H; Kim, Y; Lee, J; Jeon, J; Park, C; Moon, D
Year
2012
Is Peer Reviewed?
Yes
Journal
Anesthesia and Analgesia
ISSN:
0003-2999
EISSN:
1526-7598
Volume
115
Issue
5
Page Numbers
1228-1233
PMID
23011564
DOI
10.1213/ANE.0b013e318262e170
Web of Science Id
WOS:000310762100032
Abstract
BACKGROUND: Chemotherapy-induced peripheral neuropathy is a
common, dose-limiting side effect of cancer chemotherapeutic drugs. Hyperalgesia is a common
component of neuropathic pain. Ginkgo biloba extract (GBE) is an oriental herbal medicine that
has various pharmacological actions. In this study, we evaluated the effects of oral GBE on
hyperalgesia in a rat model of vincristine-induced neuropathy. METHODS: Male Sprague-Dawley rats
(200-250 g) were injected intraperitoneally with vincristine or saline (0.1 mg/kg/d) using a 5-
day-on, 2-day-off schedule over 12 days. All the behavioral tests for mechanical, cold, and heat
hyperalgesia were conducted before the daily injection during the course of vincristine
treatment. Rats that developed hyperalgesia 14 days after vincristine injection were randomly
assigned into 4 groups. Distilled water and GBE (50, 100, and 150 mg/kg) were administered,
respectively, to the individual groups. We examined the hyperalgesia at preadministration and at
15, 30, 60, 90, 120, 150, and 180 minutes after oral drug administration. RESULTS: Saline
injection did not have any significant effect on mechanical, cold, and heat hyperalgesia.
Vincristine injection produced mechanical and cold hyperalgesia. For the GBE groups, the paw
withdrawal threshold to mechanical stimuli was significantly increased and withdrawal frequency
to cold stimuli was significantly reduced versus the control group dose-dependently (P < 0.05).
CONCLUSIONS: This study demonstrates that oral administration of GBE is associated with a dose-
dependent antihyperalgesic effect on mechanical and cold stimuli in a rat model of vincristine-
induced neuropathy. (Anesth Analg 2012;115:1228-33)
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity